Active Lighting Intervention for Alzheimer's Disease

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Alzheimer's Disease+2 MoreTailored Lighting Intervention - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will study the long-term effects of a light treatment on cognition, sleep and metabolism in patients with MCI or mild ADRD.

Eligible Conditions
  • Alzheimer's Disease
  • Type 2 Diabetes
  • Mild Cognitive Impairment

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

4 Primary · 3 Secondary · Reporting Duration: Done at Baseline, week 13, 25 and 48

Week 13
Metabolic control
Week 13
Cognition
Depression
Light measurements
Sleep disturbance
Sleep disturbance using actigraphy
Week 13
Melatonin Levels

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Active Lighting Intervention
1 of 2
Placebo Lighting Intervention
1 of 2

Active Control

Non-Treatment Group

30 Total Participants · 2 Treatment Groups

Primary Treatment: Active Lighting Intervention · Has Placebo Group · N/A

Placebo Lighting Intervention
Device
PlaceboComparator Group · 1 Intervention: Tailored Lighting Intervention · Intervention Types: Device
Active Lighting Intervention
Device
ActiveComparator Group · 1 Intervention: Tailored Lighting Intervention · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: done at baseline, week 13, 25 and 48

Who is running the clinical trial?

Icahn School of Medicine at Mount SinaiLead Sponsor
780 Previous Clinical Trials
483,100 Total Patients Enrolled
Mariana G Figueiro, PhDPrincipal InvestigatorIcahn School of Medicine at Mount Sinai
2 Previous Clinical Trials
91 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have mild cognitive impairment.
You live at home.